Medical Abstract

Comparative Study Of Hormone Replacement, Including Transdermal And Oral Bio-Identical Natural Hormones And Homeopathic Hormone Stimulation And Rejuvenation Using Salivary Testing As A Diagnostic Tool.

Theresa Dale, Ph.D., C.C.N., N.P.
Certified Clinical Nutritionist
Traditional Naturopathic Practitioner
BioEnergetic Medical Consultant
Dean & Founder, California College of Natural Medicine
President, The Wellness Center


Using a 24-hour circadian salivary testing with specific testing times according to Traditional Chinese Medicine Five Element Body Clock, hundreds of saliva tests were analyzed. The factors used in the analysis of hormonal ratios included age, medical history of surgical procedures such as partial and/or complete hysterectomies, genetics and any type of hormone replacement usage.
All salivary testing was administered the second day of the menstrual cycle or, in the case of very infrequent menstruation or menopause, testing was administered the second day of a month.
The following hormones were analyzed: 6 cortisol levels at specific times related to organ function, progesterone, testosterone, estradiol, and DHEA levels.
Homeopathic hormone transdermal therapy was administered according to test results for a period of three, six or nine months with repeated salivary testing to monitor results.
Homeopathic meridian therapy was orally administered according to the meridian testing times that were abnormal.
A dietary regime was also administered to each client incorporating 60% raw whole foods, eliminating chemicals, and preservatives, sugar, caffeine, and alcohol.

Approximately 550 salivary tests were analyzed, and 95% of those clients using hormone ìreplacementî had abnormal hormonal ratios. 96% of those clients using bio-identical, synthetic or natural hormone replacement had elevated progesterone levels and abnormal ratios of other hormones such as cortisol, testosterone, estradiol and/or DHEA.
Of the 96% of clients using progesterone transdermal or oral replacement including bio-identical, synthetic and natural hormones, approximately 40% of clients had extremely elevated progesterone (up to 50 times greater than normal reference ranges). Clients with high progesterone reported symptomology such as hair loss, bloating, depression, insomnia, headaches, mood swings and constipation.
85% of patients with elevated salivary cortisol levels indicated a link to blood sugar problems, such as diabetes and digestive disturbances.
After using homeopathic hormone rejuvenation for three months, both to detoxify excess progesterone and stimulate production of progesterone and other hormones, symptoms improved in over 70% of cases according to personal communication with patient and repeated salivary test done by a licensed independent laboratory. After using homeopathic formulas for an additional three months, new saliva test results revealed even further progress in balancing hormone ratios including cortisol levels.
The remaining cases had definite improvement but still chose to use some prescribed hormone replacement and/or consumed an excess of alcohol, sugar and caffeine. Approximately 20% of patients testing did not indicate a need to continue homeopathic treatment after only three months.
90% of patients, whose salivary test results indicated a low DHEA level, resulted in a definite increase in DHEA in three months when a formula containing homeopathic cortisol, adrenal, hypothalamus and pituitary was applied topically during specific days of the monthly cycle.
Further salivary testing within three months of usage of homeopathic meridian therapy indicated that cortisol levels improved dramatically in 50% of patients. 45% of patients indicated moderate improvement in most cortisol level testing times that were out of balance. 5% of patients indicated minor improvement in one to six cortisol-testing times.

Progesterone and estrogen replacement can be dangerous and create a toxic build-up of hormones, even if monitored.
Hormone replacement has side effects whether it is supposedly ëbio-identicalí or even a wild yam transdermal and can cause abnormal hormone ratios.
Hormone replacement will cause the gland or organ that is responsible for specific hormone production to slow down and eventually shut down hormonal production.
Adrenal cortisol stress can be the sole cause of hot flashes and other symptoms. Cortisol in humans is the principal glucocorticoid and it influences appetite and well-being, maintains blood sugar concentrations by promoting hepatic gluconeogenesis, and indirectly affects heart rate and pumping force by controlling synthesis of epinephrine in the adrenal medulla. Therefore, since increased cortisol secretion is critical in the physiologic response to stress and illness, we can see the value of utilizing six specific cortisol level testing times to evaluate acupuncture meridian function.
Elevated progesterone levels from hormone replacement can cause adrenal stress, liver toxicity, and abnormal hormonal ratios.
Homeopathy is the only modality, thus far, that has shown the ability when formulated for this purpose to stimulate cellular communication to the hypothalamus and pituitary to make natural biological hormones strengthening the biological terrain without toxic side effects.
A diet with 60% raw unprocessed food is an extremely valuable element in the release of stress on the adrenal glands and assisting in the stabilization of cortisol and glucose levels.
This research places hormone ìreplacementî of any kind at a questionable disadvantage.


1. Orth DN, Kovaks WJ, DeBold CR: The adrenal cortex. William’s Textbook of Endocrinology, 8th ed. Wilson JD, Foster DW, Eds. WB Saunders Co, Philadelphia, 1992, p 489

2. Meikle AW, Daynes RA, Araneo BA: Adrenal androgen secretion and biologic effects. Endocrinol Metab Clin North Am 20:381, 1991 [ 1831756]
3. Quinn SJ, Williams GH: Regulation of aldosterone secretion. Ann Rev Physiol 50:409, 1988

4. Orth DN: Corticotropin-releasing hormone in humans. Endocr Rev 13:164, 1992

5. Watabe T, Tanaka K, Kumagae M, et al: Role of endogenous arginine vasopressin in potentiating corticotropin-releasing hormone-stimulated corticotropin secretion in man. J Clin Endocrinol Metab 66:1132, 1988 [ 2836468]

6. Salata RA, Jarrett DB, Verbalis JG, et al: Vasopressin stimulation of adrenocorticotropin hormone (ACTH) in humans. J Clin Invest 81:766, 1988 [ 2830315]

7. Iranmanesh A, Lizarralde G, Short D, et al: Intensive venous sampling paradigms disclose high frequency adrenocorticotropin release episodes in normal men. J Clin Endocrinol Metab 71:1276, 1990

8. Dallman MF, Akana SF, Levin N, et al: Corticosteroids and the control of function in the hypothalamo-pituitary-adrenal (HPA) axis. Ann NY Acad Sci 746:22, 1994 [ 7825879]

9. Findling JW, Engeland WC, Raff H: The use of immunoradiometric assay for the measurement of ACTH in human plasma. Trends in Endocrinol Metab 1:283, 1990

10. Kaye TB, Crapo L: The Cushing syndrome: an update on diagnostic tests. Ann Intern Med 112:434, 1990

11. Kannan CR: Diseases of the adrenal cortex. DM 34:613, 1988

12. Seeler LR: Cushing’s syndrome. Cleve Clin J Med 55:329, 1988

13. Biller BMK, Alexander JM, Zervas NT, et al: Clonal origins of adrenocorticotropin-secreting pituitary tissue in Cushing’s disease. J Clin Endocrinol Metab 75:1303, 1992

14. Odell WD: Ectopic ACTH secretion: a misnomer. Endocrinol Metab Clin North Am 20:371, 1991

15. Ulick S, Wang JZ, Blumenfeld JD, et al: Cortisol inactivation overload: a mechanism of mineralocorticoid hypertension in the ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab 74:963, 1992 [ 1569172]

16. Williams GH: Guardian of the gate: receptors, enzymes, and mineralocorticoid function (editorial). J Clin Endocrinol Metab 74:961, 1992

17. Belsky JL, Cuello B, Swanson LW, et al: Cushing’s syndrome due to ectopic production of corticotropin-releasing factor. J Clin Endocrinol Metab 60:496, 1985 [ 2982899]

18. King DR, Lack EE: Adrenal cortical carcinoma: a clinical and pathologic study of 49 cases. Cancer 44:239, 1979 [ 455249]

19. Malchoff CD, MacGillivray D, Malchoff DM: Adrenocorticotropic hormone-independent adrenal hyperplasia. Endocrinologist 6:79, 1996

20. Hermus AR, Pieters GF, Smals AG, et al: Transition from pituitary-dependent to adrenal-dependent Cushing’s syndrome. N Engl J Med 318:966, 1988

21. Young WF Jr, Carney JA, Musa BU, et al: Familial Cushing’s syndrome due to primary pigmented nodular adrenocortical disease: reinvestigation 50 years later. N Engl J Med 321:1659, 1989

22. Reznik Y, Allali-Zerah V, Chayvialle JA, et al: Food-dependent Cushing’s syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide. N Engl J Med 327:981, 1992

23. Lacroix A, Bolte E, Tremblay J, et al: Gastric inhibitory polypeptide-dependent cortisol hypersecretion-a new cause of Cushing’s syndrome. N Engl J Med 327:974, 1992

24. Bertagna X: New causes of Cushing’s syndrome (editorial). N Engl J Med 327:1024, 1992

25. Kreisberg R: Half a loaf. N Engl J Med 330:1295, 1994

26. Findling JW: Clinical application of a new immunoradiometric assay for ACTH. Endocrinologist 2:360, 1992

27. Snow K: Biochemical evaluation of adrenal dysfunction: the laboratory perspective. Mayo Clin Proc 67:1055, 1992

28. Flack MR, Oldfield EH, Cutler GB Jr, et al: Urine free cortisol in the high-dose dexamethasone suppression test for the differential diagnosis of the Cushing syndrome. Ann Intern Med 116:211, 1992 29.

30. Zarate A, Kovaks K, Flores M, et al: ACTH and CRF-producing bron chial carcinoid associated with Cushing’s syndrome. Clin Endocrinol 24:523, 1986

31. Grossman AB, Howlett TA, Perry L, et al: CRF in the differential diagnosis of Cushing’s syndrome: a comparison with the dexamethasone suppression test. Clin Endocrinol 29:167, 1988

32. Nieman LK, Cutler GB Jr, Oldfield EH, et al: The ovine corticotropin-releasing hormone (CRH) stimulation test is superior to the human CRH stimulation test for the diagnosis of Cushing’s disease. J Clin Endocrinol Metab 69:165, 1989

33. Schulte HM, Allolio B, Gunther TK, et al: Bilateral and simultaneous sinus petrosus inferior catheterization in patients with Cushing’s syndrome: plasma-immunoreactive-ACTH-concentrations before and after administration of CRF. Horm Metab Res (suppl) 16:66, 1987

34. Loriaux DL, Nieman L: Corticotropin-releasing hormone testing in pituitary disease. Endocrinol Metab Clin North Am 20:363, 1991

35. Malchoff CD, Orth DN, Abboud C, et al: Ectopic ACTH syndrome caused by a bronchial carcinoid tumor responsive to dexamethasone, metyrapone, and corticotropin-releasing factor. Am J Med 84:760, 1988

36. Gold PW, Loriaux DL, Roy A, et al: Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing’s disease. N Engl J Med 314:1329, 1986

39. Groote Veldman R, Meinders AE: On the mechanism of alcohol-induced pseudo-Cushing’s syndrome. Endocr Rev 17:262, 1996

40. Prevalence of 3-hydroxysteroid dehydrogenasedeficient nonclassic adrenal hyperplasia in hyperandrogenic women with adrenal androgen excess American Journal of Obstetrics and Gynecology September 1999 ï Volume 181 ï Number 3 Carlos Moran, MD, MS, H. Downing Potter, BS, Rosario Reyna, BS, d, Larry R. Boots, PhD, Ricardo Azziz, MD, MPH.

41. 1: J Nutr 2001 May;131(5):1621S-5S Human saliva as a diagnostic specimen. Hofman LF. Saliva Testing and Reference Laboratory, Inc., Seattle, WA 98104. PMID: 11340128 [PubMed – in process]

42. 1: Endocr Res 2000 Nov;26(4):489-504 Fetal hypothalamic-pituitary adrenal (HPA) development and activation as a determinant of the timing of birth, and of postnatal disease. Challis J, Sloboda D, Matthews S, Holloway A, Alfaidy N, Howe D, Fraser M, Newnham J. Department of Physiology, University of Toronto, Ontario, Canada.2PMID: 11196419 [PubMed – indexed for MEDLINE]

43. Van Goozen SH, Weigant VM, Endert E, Helmond FA, Van de Poll NE. Psychoendocrinological assessment of the menstrual cycle: the relationship between hor-mones, sexuality, and mood. Arch Sex Behav 1997;26(4):359-382.

44. Lee KA, Shaver JF, Giblin EC, Woods NF. Sleep patterns related to menstrual cycle phase and premenstrual affective symptoms. Sleep 1990; 13(5):403-409.

45. Dye L, Blundell JE. Menstrual cycle and appetite control: implications for weight regu-lation. Hum Reprod 1997;12(6):1142-1151.

46. Redei E, Freeman EW. Daily plasma estradiol and progesterone levels over the menstrual cycle and their relation to premenstrual symp-toms. Psychoneuroendocrinol 1995; 20(30):259-267.

47. De Boever J, Kohen F, Bouve J, Leyseele D,Vandekerckhove D. Direct chemilumines-cence immunoassay of estradiol in saliva. Clin Chem 1990;36:2036-41.

48. Wong Y, Mao K, Panesar NS, Loong EP, Chang AM, Mi ZJ. Salivary estradiol and prog-esterone during the normal ovulatory menstru-al cycle in Chinese women. Eur J Obst Gynecol and Rep Biol 1990;34:129-35.

49. Vining R, McGinley R, and Symons R. Hormones in saliva: mode of entry and conse-quent implications for clinical interpretation. Clin Chem 1983;29:1752-56.

50. Bhagavan NV. Medical Biochemistry. Boston: Jones and Bartlett Publishers; 1992, 805-807.

51. Vuorento T, Lahti A, Hovatta O, and Huhtaniemi I. Daily measurements of salivary progesterone reveal a high rate of anovulation in healthy students. Scan J Clin Lab Invest 1989;49:395-401.

52. Danutra V, Turkes A, Read G, Wilson D, Griffiths V, Jones R, Griffiths K. Progesterone concentrations in samples of saliva from ado-lescent girls living in Britain and Thailand, two countries where women are at widely differing risk of breast cancer. J Endocrin 1988; 121:375-81.

53. Finn M, Gosling J, Tallon D, Joyce L, Meehan F, Fottrell P. Follicular growth and corpus luteum function in women with unexplained infertility, monitored by ultrasonography and measurement of daily progesterone. Gynecol Endocrin 1989;3:297-308.

54. Vuorento T, Hovatta O, Kurunmaki H, Ratsula K, Huhtaneimi I. Measurements of salivary progesterone throughout the menstrual cycle in women suffering from unexplained infertility reveal high frequency of luteal phase defects. Fertil Steril 1990;54:211-16.

55. Vuorento T, and Huhtaniemi I. Daily measure-ments of salivary progesterone during men-strual cycle in adolescent girls. Fertil Steril 1992;58:685-90.

56. Wren B. Reproductive endocrinology. In: Hacker N and Moore J., editors. Essentials of obstetrics and gynecology. Philadelphia: W. B. Sanders Co., 1992.

57. Ronkainen H, et al. Physical exercise-induced changes and season-associated differences in the pituitary-ovarian function of runners and joggers. J Clin Endocrin Metab 1985;60:416.

58. Lipson S and Ellison P. Normative study of age variation in salivary progesterone profiles. J Biosoc Sci 1992;24:233-44.

59. Hamilton C, Wetzels L, Evers J, Hoogland H, Muijtjens A, de Haan J. Follicle growth curves and hormonal patterns in patients with luteinized unruptured follicle syndrome. Fertil Steril 1985;43:541-48.

60. van Zonneveld P, te Velde E, Koppeschaar H. Low luteal phase serum progesterone levels in regularly cycling women are predictive of sub-tle ovulating disorders. Gynecol Endocrin 1994;8:169-74.

61. Ayers J, Birenbuam DL, Menon KM. Luteal phase dysfunction in endometriosis: elevated progesterone levels in peripheral and ovarian veins during the follicular phase. Fertil Steril 1987;47:935-39.

62. Wingfield M, OíHerlihy C, Finn M, Tallon D, Fottrell P. Follicular and luteal phase salivary progesterone profiles in women with endometriosis and infertility. Gynecol Endocrin 1994;8:21-25.

63. Pirke KM, Schweiger U, Laessle R, Dickhaut B, Schweiger M, Waechtler M. Dieting influences the menstrual cycle: vegetarian versus nonvege-tarian diet. Fertil Steril 1986;46:1083.

64. Karmen B. Hormone replacement therapy: yes or no? Novato, CA: Nutrition Counter, Inc., 1993.

65. Wilson D, Turkes A, Jones R, Danutra V, Read G, Griffiths K. A comparison of menstrual cycle profiles of salivary progesterone in British and Thai adolescent girls. Eur J Cancer 1992; 28A:1162-67.

66. De Cree C, Lewin R, Ostyn M. The monitoring of the menstrual status of female athletes by salivary steroid determination and ultrasonog-raphy. Eur J App Physiol 1990;60:472-77.

67. Keizer H. Exercise- and training-induced men-strual cycle irregularities (AMI). Int J Sports Med 1986;8(suppl 3):137-74.

68. Keizer H, Poortman J, Bunnick G. Influence of physical exercise on sex steroid metabolism. J Appl Physiol 1980;48:765-69.

69. Wentz A. Cigarette smoking and fertility. Fertil Steril 1986;46:365. 41A41